CALT - Cup and HandleAn idea showing a clear Cup or rounded formation on CALT.
Im just forecasting a handle situation due to the fact of the presence of this cup.
Price is above a down channel which is good for this scenario.
−1.64USD
−43.91 MUSD
113.69 MUSD
26.77 M
About Calliditas Therapeutics AB
Sector
CEO
Renée Julie Elisabet Aguiar-Lucander
Headquarters
Stockholm
Website
Founded
2004
ISIN
US13124Q1067
FIGI
BBG00TW5HX80
Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications. The firm focuses on renal and hepatic diseases with significant unmet medical needs. It offers Nefecon, a proprietary, novel oral formulation of budesonide for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN. The firm product TARPEYO is used to reduce proteinuria in adults with primary immunoglobulin. The company was founded by Mikael Bender and Bengt Åke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden.
CALT BUY/LONG NOW READY! 31.00 to 39.45 by Aug 2021TICKER CODE: CALT
Company Name: CALLIDITAS THERAPEUTICS AB
US Stocks Health Technology Pharmaceuticals: Major
Position Proposed: BUY
BUY ENTRY: NOW READY (31.00)
1st Partial Take Profit: 39.45 (July - August 2021)
2nd Partial Take Profit: 47.80 (End 2021)
NOTE THAT THE TIMELINE IS ONLY AN ESTIMA
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
